Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Vasogen-- VAS on TSE -- Ignore unavailable to you. Want to Upgrade?

To: Stephen O who wrote (294)	7/26/2005 1:06:16 PM
From: Pluvia	Read Replies (2) \| Respond to of 377

If what they have works then that is the dose. If it is really succesful, the medical community will want it. 1. the medical community does not regulate new drugs [unless i'm mistaken, the FDA still has that job] 2. dose of? what? vasogen doesn't know what their drug "is" and their drug is chemically different for each patient. so how would the fda regulate a compound vasogen can't and has not identified? do you really think the fda will approve a drug that the sponsor can't identify? inquiring minds want to know.